Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.11 | 35.97 |
PEG Ratio (TTM) | -0.02 | -3.30 |
P/S Ratio (TTM) | 0.80 | 6.49 |
P/B Ratio (TTM) | -0.43 | 4.55 |
P/FCF Ratio (TTM) | -0.55 | 45.89 |
Price to 5YR AVG Earnings Ratio | N/A | 63.05 |
Price to 5YR AVG FCF Ratio | N/A | 34.84 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -48.84% | 5.11% |
ROE (TTM) | 36.54% | 25.64% |
Net Profit Margin (TTM) | -71.24% | -0.60% |
ROIC 5YR AVG | N/A | 3.54% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -48.02% | -412.58% | N/A |
Revenue | -17.45% | 17.06% | N/A |
Net Income | -78.68% | -79,947.87% | N/A |
Cash Flow | 9.12% | -13,646,721.35% | N/A |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.33 | 2.59 |
Quick Ratio (TTM) | 2.09 | 1.96 |
D/E Ratio (TTM) | -0.57 | -0.06 |
Interest Coverage (TTM) | -10.65 | 12.58 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 7.12 |
LTL to 5YR AVG FCF | N/A | 3.63 |
Shares Outstanding Growth 5YR AVG | N/A | 2.50% |